Skip to main content

Table 3 Clinicopathological characteristics according to EGFR mutation status

From: Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity

 

EGFR positive

EGFR negative

P value

N

119

98

 

Age

63.50 ± 9.11

62.68 ± 11.35

0.559

Sex (M:F)

43:76

55:43

0.003

PYR

5.805 ± 14.426

14.031 ± 19.193

<0.001

Pathologic stage

117*

95*

0.199

  0

6

9

 

  IA

87

57

 

  IB

18

18

 

  IIA

1

5

 

  IIB

2

0

 

  IIIA

3

5

 

  IIIB

0

1

 

Nodal involvement

5

10

0.106

Histologic invasiveness

118†

98

0.600

  AIS

6

9

 

  MIA

11

5

 

  IA

101

84

 

Maximal diameter

22.387 ± 9.876

22.376 ± 12.052

0.507

Solid diameter

11.133 ± 11.229

12.559 ± 11.257

0.353

TDR

0.702 ± 0.295

0.687 ± 0.290

0.720

  1. *Data for pathologic stage were unavailable for 2 EGFR positive and 3 EGFR negative patients.
  2. †Data for histologic invasiveness were unavailable for 1 patient.